Literature DB >> 26301207

Blood-Brain Barrier Permeability in Aging and Alzheimer's Disease.

G A Rosenberg1.   

Abstract

Entities:  

Year:  2014        PMID: 26301207      PMCID: PMC4543304          DOI: 10.14283/jpad.2014.25

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN: 2274-5807


× No keyword cloud information.
  25 in total

1.  Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.

Authors:  Anika M S Hartz; Björn Bauer; Emma L B Soldner; Andrea Wolf; Sandra Boy; Roland Backhaus; Ivan Mihaljevic; Ulrich Bogdahn; Hans H Klünemann; Gerhard Schuierer; Felix Schlachetzki
Journal:  Stroke       Date:  2011-11-23       Impact factor: 7.914

2.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.

Authors:  Robert D Bell; Ethan A Winkler; Itender Singh; Abhay P Sagare; Rashid Deane; Zhenhua Wu; David M Holtzman; Christer Betsholtz; Annika Armulik; Jan Sallstrom; Bradford C Berk; Berislav V Zlokovic
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

3.  Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study.

Authors:  John M Starr; Andrew J Farrall; Paul Armitage; Brian McGurn; Joanna Wardlaw
Journal:  Psychiatry Res       Date:  2009-02-10       Impact factor: 3.222

4.  High blood pressure and microinfarcts: a link between vascular risk factors, dementia, and clinical Alzheimer's disease.

Authors:  Julie A Schneider
Journal:  J Am Geriatr Soc       Date:  2009-11       Impact factor: 5.562

5.  Ecology of the aging human brain.

Authors:  Joshua A Sonnen; Karen Santa Cruz; Laura S Hemmy; Randall Woltjer; James B Leverenz; Kathleen S Montine; Clifford R Jack; Jeffrey Kaye; Kelvin Lim; Eric B Larson; Lon White; Thomas J Montine
Journal:  Arch Neurol       Date:  2011-08

6.  Blood-brain barrier permeability abnormalities in vascular cognitive impairment.

Authors:  Saeid Taheri; Charles Gasparovic; Branko N Huisa; John C Adair; Elaine Edmonds; Jillian Prestopnik; Mark Grossetete; N Jon Shah; John Wills; Clifford Qualls; Gary A Rosenberg
Journal:  Stroke       Date:  2011-06-30       Impact factor: 7.914

7.  Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.

Authors:  Stephen Salloway; Reisa Sperling; H Robert Brashear
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

8.  Blood-brain barrier integrity in Alzheimer's disease patients and elderly control subjects.

Authors:  M T Caserta; D Caccioppo; G D Lapin; A Ragin; D R Groothuis
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1998       Impact factor: 2.198

Review 9.  Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.

Authors:  E Candelario-Jalil; Y Yang; G A Rosenberg
Journal:  Neuroscience       Date:  2008-06-19       Impact factor: 3.590

Review 10.  Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment.

Authors:  Gary A Rosenberg; Maria Bjerke; Anders Wallin
Journal:  Stroke       Date:  2014-04-01       Impact factor: 7.914

View more
  20 in total

1.  Hyperfibrinogenemia-mediated astrocyte activation.

Authors:  Vincent D Clark; Ailey Layson; Mariam Charkviani; Nino Muradashvili; David Lominadze
Journal:  Brain Res       Date:  2018-08-25       Impact factor: 3.252

Review 2.  Cerebral microhemorrhages due to traumatic brain injury and their effects on the aging human brain.

Authors:  Andrei Irimia; John D Van Horn; Paul M Vespa
Journal:  Neurobiol Aging       Date:  2018-03-06       Impact factor: 4.673

3.  Neuroinflammatory disease disrupts the blood-CNS barrier via crosstalk between proinflammatory and endothelial-to-mesenchymal-transition signaling.

Authors:  Zhonglou Sun; Helong Zhao; Daniel Fang; Chadwick T Davis; Dallas S Shi; Kachon Lei; Bianca E Rich; Jacob M Winter; Li Guo; Lise K Sorensen; Robert J Pryor; Nina Zhu; Samuel Lu; Laura L Dickey; Daniel J Doty; Zongzhong Tong; Kirk R Thomas; Alan L Mueller; Allie H Grossmann; Baowei Zhang; Thomas E Lane; Robert S Fujinami; Shannon J Odelberg; Weiquan Zhu
Journal:  Neuron       Date:  2022-08-11       Impact factor: 18.688

Review 4.  Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

Review 5.  MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies.

Authors:  Rajikha Raja; Gary A Rosenberg; Arvind Caprihan
Journal:  Neuropharmacology       Date:  2017-10-28       Impact factor: 5.250

6.  Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[11 C]verapamil in elderly vs. young subjects.

Authors:  Martin Bauer; Beatrix Wulkersdorfer; Rudolf Karch; Cécile Philippe; Walter Jäger; Johann Stanek; Wolfgang Wadsak; Marcus Hacker; Markus Zeitlinger; Oliver Langer
Journal:  Br J Clin Pharmacol       Date:  2017-05-04       Impact factor: 4.335

Review 7.  Understanding the brain uptake and permeability of small molecules through the BBB: A technical overview.

Authors:  Ekram Ahmed Chowdhury; Behnam Noorani; Faleh Alqahtani; Aditya Bhalerao; Snehal Raut; Farzane Sivandzade; Luca Cucullo
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-14       Impact factor: 6.200

8.  Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's disease.

Authors:  Carmen M Fernandez-Martos; Rachel A K Atkinson; Meng I Chuah; Anna E King; James C Vickers
Journal:  Alzheimers Dement (N Y)       Date:  2016-12-20

9.  96 perfusable blood vessels to study vascular permeability in vitro.

Authors:  V van Duinen; A van den Heuvel; S J Trietsch; H L Lanz; J M van Gils; A J van Zonneveld; P Vulto; T Hankemeier
Journal:  Sci Rep       Date:  2017-12-22       Impact factor: 4.379

Review 10.  Current Strategies for Brain Drug Delivery.

Authors:  Xiaowei Dong
Journal:  Theranostics       Date:  2018-02-05       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.